iRhythm Technologies Inc. (IRTC)

84.94
NASDAQ : Health Technology
Prev Close 91.22
Day Low/High 84.83 / 90.46
52 Wk Low/High 55.18 / 98.37
Avg Volume 377.20K
Exchange NASDAQ
Shares Outstanding 24.46M
Market Cap 2.23B
EPS -2.00
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week Of January 2019 Options Trading For IRhythm Technologies (IRTC)

First Week Of January 2019 Options Trading For IRhythm Technologies (IRTC)

Investors in iRhythm Technologies Inc saw new options begin trading this week, for the January 2019 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IRTC options chain for the new January 2019 contracts and identified one put and one call contract of particular interest.

Interesting IRTC Put And Call Options For May 2019

Interesting IRTC Put And Call Options For May 2019

Investors in iRhythm Technologies Inc saw new options begin trading this week, for the May 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 203 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

IRhythm Technologies Enters Oversold Territory (IRTC)

IRhythm Technologies Enters Oversold Territory (IRTC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

New iPhone Winners May Include T-Mobile and Intel, but Not Qualcomm

New iPhone Winners May Include T-Mobile and Intel, but Not Qualcomm

While T-Mobile scored a double victory with the new iPhones, it is not the only winner.

Zio By IRhythm Shown To Improve Detection Of Previously Undiagnosed Atrial Fibrillation

Zio By IRhythm Shown To Improve Detection Of Previously Undiagnosed Atrial Fibrillation

Results of Study Presented at American College of Cardiology Annual Scientific Sessions

You Can't Have it Both Ways: Cramer's 'Mad Money' Recap (Wed 1/10/18)

You Can't Have it Both Ways: Cramer's 'Mad Money' Recap (Wed 1/10/18)

Jim Cramer says people can't have it both ways when it comes to worrying about the bond market and stocks.

Toyota, Southwest Airlines, iRhythm Technologies: 'Mad Money' Lightning Round'

Toyota, Southwest Airlines, iRhythm Technologies: 'Mad Money' Lightning Round'

Jim Cramer is bullish on Toyota, Southwest Airlines, iRhythm Technologies, General Dynamics, Raytheon, Lockheed Martin.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: HABT, MTCH, NTIC, PERY, PPIH, TGH, VRS Downgrades: CRTO, EEI, KEYW, NLSN, PANW, UAL, USM, VICR Initiations: AA, FRTA, IRTC, QCP Read on to get TheStreet Quant Ratings' detailed report:

Strange: Bullish IRTC Analysts Actually See -7.61% Downside

Strange: Bullish IRTC Analysts Actually See -7.61% Downside

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with iRhythm Technologies Inc . The average 12-month price target for IRTC — averaging the work of 4 analysts — reveals an average price target of $46.75/share.

Strange: Bullish IRTC Analysts Actually See -15.98% Downside

Strange: Bullish IRTC Analysts Actually See -15.98% Downside

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with iRhythm Technologies Inc . The average 12-month price target for IRTC — averaging the work of 4 analysts — reveals an average price target of $40.75/share.

Strange: Bullish IRTC Analysts Actually See -7.01% Downside

Strange: Bullish IRTC Analysts Actually See -7.01% Downside

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with iRhythm Technologies Inc . The average 12-month price target for IRTC — averaging the work of 4 analysts — reveals an average price target of $40.75/share.

IRhythm Technologies Announces Second Quarter 2017 Financial Results

IRhythm Technologies Announces Second Quarter 2017 Financial Results

Raises Guidance for Full Year 2017

Strange: Bullish IRTC Analysts Actually See -9.97% Downside

Strange: Bullish IRTC Analysts Actually See -9.97% Downside

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with iRhythm Technologies Inc . The average 12-month price target for IRTC — averaging the work of 4 analysts — reveals an average price target of $37.75/share.

New Expert Statement Recognizes Patch Monitors Such As Zio By IRhythm As Effective For Atrial Fibrillation Monitoring Post-Ablation

Confirms Value of Extended Continuous Cardiac Monitoring in Symptomatic and Asymptomatic Post-Ablation Patients

IRTC Crosses Above Average Analyst Target

In recent trading, shares of iRhythm Technologies Inc have crossed above the average analyst 12-month target price of $37.75, changing hands for $38.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

New Study Confirms Extended Continuous Cardiac Monitoring Is More Efficient Than Holter Monitoring For Cryptogenic Stroke Patients

Data Presented at the European Stroke Organisation Conference Shows Zio® by iRhythm Cardiac Monitoring Shortens Time to Diagnosis After Cryptogenic Stroke

IRhythm Technologies Announces First Quarter 2017 Financial Results

Raises Guidance for Full Year 2017

iRhythm Technologies Reaches Analyst Target Price

In recent trading, shares of iRhythm Technologies Inc have crossed above the average analyst 12-month target price of $34.75, changing hands for $35.24/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Zio By IRhythm Gains Further Recognition As Key Diagnostic Cardiac Monitoring System By US And UK Health Organizations

Zio system becoming standard of care for diagnosis and management of arrhythmias; could be more efficient and accurate than legacy monitors in arrhythmia detection

TheStreet Quant Rating: D+ (Sell)